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Neoplastic meningitis occurs in approximately 5% of patients with cancer. Primary diffuse leptomeningeal 
gliomatosis is a rare condition whereby a glioma arises from heterotopic cell nests in the leptomeninges. We report 
here a case presenting with clinical features similar to those of chronic infectious meningitis without positive 
cerebrospinal fluid cytology. Neurological signs in our patient deteriorated progressively without responding to 
antitubercular, antiviral, or antibiotic therapy. Leptomeningeal biopsy sampling revealed the condition to be primary 
diffuse leptomeningeal gliomatosis.
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Neoplastic meningitis is diagnosed in up to 15% of 
patients with non-central-nervous-system primary cancers 
and 1~2% of patients with primary brain tumors.
1 Primary 
diffuse leptomeningeal gliomatosis (PDLG) is a rare 
fatal condition that is characterized by a glioma from 
heterotopic cell nests in the leptomeninges, in which the 
cells infiltrate the meninges in the absence of an 
intraparenchymal tumor.
3
Diagnosis of PDLG requires the fulfillment of three 
criteria: (1) no attachment of the tumor to the brain 
parenchyma, (2) no evidence of intra-axial lesions, and 
(3) the presence of leptomeningeal encapsulation of the 
tumor.
2
Only 30 cases of PDLG have been reported,
5 and only 
1 of those cases had a positive cytology,
4 suggesting that 
negative cerebrospinal fluid (CSF) cytology is common.
We report here the first case of PDLG in Korea, which 
presented clinical features similar to those of chronic 
infectious meningitis.
CASE REPORT
A 22-year-old military officer was transferred to our 
hospital in a comatose condition and with progressive 
hydrocephalus that had developed 6 months before. Until 
6 months before his first admission to hospital, the 
patient was in good health, but then several episodes of 
generalized tonic seizures occurred and he became Kim SH, et al. Primary Diffuse Leptomeningeal Gliomatosis 
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stuporous and developed a fever above 38℃. An initial 
brain computed tomography (CT) scan taken at that time 
was not remarkable. CSF analysis revealed an opening 
pressure of 27 cm H2O, pale yellow color, pleocytosis 
with 12 lymphocytes/mm
3, and protein and glucose 
levels of 11350 mg/L and 10 mg/L, respectively. The 
following CSF investigations all produced negative 
results: bacterial culture, acid-fast blue staining, poly-
merase chain reaction for tuberculosis, varicella zoster, 
and herpes simplex, India ink staining, fungus culture, 
and viral culture. CSF cytology revealed many lympho-
cytes with a few atypical, insignificant lymphocytes. 
Following an initial diagnosis of viral or tuberculous 
meningoencephalitis, acyclovir and antitubercular me-
dicine, including intravenous dexamethasone, were 
administered empirically. Despite this, the patient’s 
intracranial pressure continued to increase, his mentality 
worsened, and he became comatose.
He was transferred to our hospital for further 
evaluation and treatment. On neurological examination it 
was noted that his vestibulo-ocular reflex was impaired 
bilaterally. All four limbs extended in response to pain-
ful stimuli, with bilateral extensor toe signs. There was 
a severe neck stiffness. Brain magnetic resonance 
imaging (MRI) performed at 8 months after symptom 
onset revealed severe hydrocephalus and strongly 
enhanced leptomeninges with a leptomeningeal-enhancing 
nodular mass above the corpus callosum (Fig. 1).
Extraventricular drainage was performed to decrease 
the intracranial pressure and a leptomeningeal biopsy 
procedure was carried out by open craniotomy. Subse-
quent histopathological investigations revealed a marked 
hypercellularity and nuclear pleomorphism with geo-
graphic pseudopalisading necrosis (Fig. 2). There was no 
infiltration in the adjacent brain parenchyma, which con-
firmed the diagnosis of leptomeningeal glioblasto-
matosis.
His condition deteriorated progressively in spite of 
medical treatments, and the patient died due to brain 
herniation 9 months after symptom onset.
Figure 1. T1-weighted axial and sagittal brain MRI. There was 
extensive hydrocephalus and marked thickening of the meninges with 
prominent gadolinium enhancement, and a leptomeningeal-enhancing 
nodular mass above the corpus callosum.Journal of Clinical Neurology: Vol. 2, No. 3, 2006
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Figure 2. Biopsy of the leptomeningeal mass above the corpus callosum. (A) Hematoxylin-eosin-stained meningeal tumor with marked
hypercellularity, nuclear pleomorphism, geographic pseudopalisading necrosis, and venous endothelial hyperplasia (×100). (B) Positive 
glial fibrillary acidic protein staining of the tumor cells (×200).
DISCUSSION
The clinical manifestations in our patient resembled 
chronic infectious meningitis with negative CSF cyto-
logy, such as tuberculous meningitis or fungal menin-
gitis.
Neoplastic meningitis is diagnosed in 4~15% of 
patients with solid tumors (carcinomatous meningitis), 
5~15% of patients with leukemia and lymphoma 
(leukemic or lymphomatous meningitis), and 1~2% of 
patients with primary brain tumors.
1 The present patient 
had a leptomeningeal irritation sign, and the CSF study 
and brain MRI were compatible with the diagnosis of 
chronic infectious meningitis. However, his medical status 
deteriorated in spite of antibiotic and steroid therapy. A 
brain MRI revealed a leptomeningeal mass in the subara-
chnoid space above the corpus callosal area, and biopsy 
sampling confirmed the diagnosis of PDLG.
PDLG is a fatal primary brain tumor with malignant 
glial cell infiltration in the meninges without the 
presence of an intraparenchymal tumor.
3 This patient 
met the three conditions of diagnostic criteria compatible 
with PDLG. This condition is usually confirmed only at 
postmortem during an autopsy. We performed a biopsy 
procedure, which revealed no involvement of the brain 
parenchyma adjacent to the tumor, and this finding 
provided evidence that malignant glial cells were present 
only in the CSF space. That there was no invasion of 
the brain parenchyma was confirmed by brain MRI. A 
limitation of our report is that we did not perform an 
autopsy to confirm our diagnosis unequivocally.
According to a review of 15 previously reported 
PDLG cases, frequent symptoms of PLDG are intra-
cranial hypertension (44%), cranial nerve palsies (56%), 
meningism (44%), and seizures (44%).
3 Initial CT scan 
findings are frequently unremarkable except for ventri-
cular dilatation, and the most common MRI finding is a 
leptomeningeal enhancement.
3 With respect to CSF cyto-
logy, previous reports suggest that patients with 
secondary meningeal gliomatosis often have tumor cells, 
but that negative cytology seems to be a common 
finding in PDLG, and only 1 of 24 cases on record had 
a positive cytology.
4 Our patient experienced increased 
intracranial pressure and a seizure at the onset of disease 
development. MRI revealed only dural enhancement and 
hydrocephalus with negative CSF cytology, which were 
similar to other reported cases.
In conclusion, we report here a case of a PLDG, 
which can be considered as a differential diagnosis for 
chronic infectious meningitis of unknown origin, and is 
intractable to the medical treatment.Kim SH, et al. Primary Diffuse Leptomeningeal Gliomatosis 
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